| PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity CR Funk, S Wang, KZ Chen, A Waller, A Sharma, CL Edgar, VA Gupta, ... Blood, The Journal of the American Society of Hematology 139 (4), 523-537, 2022 | 74 | 2022 |
| Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study S Pakkala, K Higgins, Z Chen, G Sica, C Steuer, C Zhang, G Zhang, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 39 | 2020 |
| Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma S Ravindranathan, T Passang, JM Li, S Wang, R Dhamsania, MB Ware, ... Nature Communications 13 (1), 6418, 2022 | 11 | 2022 |
| Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression J Zhu, Y Wang, J Li, PK Das, H Zhang, T Passang, JM Li, T Nagy, ... Blood, The Journal of the American Society of Hematology 140 (12), 1431-1447, 2022 | 9 | 2022 |
| A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC). TK Owonikoko, KA Higgins, Z Chen, C Zhang, RN Pillai, CE Steuer, ... Journal of Clinical Oncology 37 (15_suppl), 8515-8515, 2019 | 9 | 2019 |
| Suppression of graft-versus-host disease and retention of graft-versus-tumour reaction by murine genetically engineered dendritic cells following bone marrow transplantation Y Huang, S Feng, Y Xu, W Chen, S Wang, D Li, Z Li, Q Lu, X Pan, K Xu Molecular Medicine Reports 11 (5), 3820-3827, 2015 | 7 | 2015 |
| 调节性树突状细胞与免疫耐受 王淑华， 黄一虹 医学综述 16 (10), 1459-1461, 2010 | 5 | 2010 |
| Lentivirus-mediated soluble tumor necrosis factor receptor 1 expression in mouse bone marrow-derived immature dendritic cells Y Huang, Y Chao, R Tang, S Wang, L Zeng, C Chen, X Pan, K Xu Chinese Journal of Tissue Engineering Research 14 (5), 841, 2010 | 4 | 2010 |
| PI3K δ/γ Inhibition Enhances the Expansion and Anti-Tumor Cytotoxicity of CART Cells for CLL Patients S Wang, CR Funk, S Ravindranathan, K Chen, EK Waller Blood 138, 4795, 2021 | 2 | 2021 |
| 819 Targeting vasoactive intestinal peptide receptor signaling: a novel approach to enhance anti-tumor response in pancreatic ductal adenocarcinoma S Ravindranathan, P Tenzin, S Chandrasekaran, B Ware, M Zaidi, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 2 | 2020 |
| Abstract CT045: Synergistic anti-tumor efficacy of the dual PI3K-δ/PI3K-γ inhibitor duvelisib with PD-1 blockade in solid tumor and lymphoma models S Coma, CR Funk, S Wang, EK Waller, DT Weaver, JA Pachter Cancer Research 80 (16_Supplement), CT045-CT045, 2020 | 2 | 2020 |
| Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow … SH Wang, DP Li, YJ Zhang, P Zhang, LY Zeng, XY Pan, KL Xu, YH Huang Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi 33 (2), 88-93, 2012 | 2 | 2012 |
| Duvelisib Promotes Mitochondrial Fusion and Epigenetic Reprogramming to Drive Therapeutic T Cell Persistence and Function KZ Chen, CR Funk, S Wang, A Sharma, EK Waller, M Shanmugam Blood 138, 1714, 2021 | 1 | 2021 |
| Transplanted Vasoactive Intestinal Peptide-Secreting Donor Plasmacytoid Dendritic Cells Migrate to Lymphoid Organs and GvHD Target Organs J Zhu, Y Wang, J Li, Y Li, AU Antonova, CR Giver, J Li, S Wang, EK Waller Blood 134, 1918, 2019 | 1 | 2019 |
| Dual inhibition of PI3Kdelta and PI3Kgamma to enhance mitochondrial mass and ex vivo expansion of central and stem cell memory T cells from CLL patients C Funk, S Wang, A Waller, L Fleischer, A Sharma, H Spencer, V Gupta, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 1 | 2019 |
| Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy S Ravindranathan, Y Li, S Wang, MY Zaidi, GB Lesinski, B El-Rayes, ... Cancer Research 79 (13_Supplement), 1205-1205, 2019 | 1 | 2019 |
| Vasoactive Intestinal Peptide Signaling in Transplant Recipients Modulates Gut Microbiome Diversity and Regulates Graft-Versus-Host Disease YH Li, S Wang, EK Waller Blood 142, 2046, 2023 | | 2023 |
| Donor T Cell Infusions Limit Novel Immune Checkpoint Therapy in Pancreatic Cancer: Implications for Adoptive T Cell Therapy PC Hsu, EK Waller, T Passang, S Wang, JM Li Blood 142, 2144, 2023 | | 2023 |
| Early Plasma Levels of IL7 and IL15 Predict Response to Chimeric Antigen Receptor T Cell Therapy (CAR-T) in Large B-Cell Lymphoma (LBCL) Patients F Zeng, H Zhang, S Wang, T Passang, YH Li, CR Funk, S Wyman, ... Blood 142, 6112, 2023 | | 2023 |
| NOVEL IMMUNOTHERAPY FOR AML JM Li, N Papdantonakis, S Wang, J Liu, T Passang, C Giver, T Owonikoko, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 115-116, 2023 | | 2023 |
